
Bong-sook Baek
Examiner (ID: 19234, Phone: (571)270-5863 , Office: P/1621 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1629, 1614, 1611, 1621, 4161 |
| Total Applications | 1191 |
| Issued Applications | 499 |
| Pending Applications | 85 |
| Abandoned Applications | 621 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13699565
[patent_doc_number] => 20170360737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => LONG-CHAIN POLYUNSATURATED FATTY-ACID-CONTAINING FAT AND FOOD CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 15/522377
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522377 | LONG-CHAIN POLYUNSATURATED FATTY-ACID-CONTAINING FAT AND FOOD CONTAINING SAME | Sep 28, 2015 | Abandoned |
Array
(
[id] => 15751175
[patent_doc_number] => 10617670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Synergistic auristatin combinations
[patent_app_type] => utility
[patent_app_number] => 15/516780
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 11
[patent_no_of_words] => 13693
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/516780 | Synergistic auristatin combinations | Sep 28, 2015 | Issued |
Array
(
[id] => 12016864
[patent_doc_number] => 09809556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Treatment of amyotrophic lateral sclerosis'
[patent_app_type] => utility
[patent_app_number] => 14/867624
[patent_app_country] => US
[patent_app_date] => 2015-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 50
[patent_no_of_words] => 53559
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14867624
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/867624 | Treatment of amyotrophic lateral sclerosis | Sep 27, 2015 | Issued |
Array
(
[id] => 13368753
[patent_doc_number] => 20180235917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA
[patent_app_type] => utility
[patent_app_number] => 15/513115
[patent_app_country] => US
[patent_app_date] => 2015-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513115
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/513115 | COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA | Sep 22, 2015 | Abandoned |
Array
(
[id] => 10553903
[patent_doc_number] => 09278095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-08
[patent_title] => 'Bupropion as a modulator of drug activity'
[patent_app_type] => utility
[patent_app_number] => 14/863284
[patent_app_country] => US
[patent_app_date] => 2015-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26846
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863284
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/863284 | Bupropion as a modulator of drug activity | Sep 22, 2015 | Issued |
Array
(
[id] => 12656764
[patent_doc_number] => 20180110754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 15/549958
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549958
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549958 | CENICRIVIROC FOR THE TREATMENT OF FIBROSIS | Sep 21, 2015 | Abandoned |
Array
(
[id] => 11656022
[patent_doc_number] => 09669002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Use for cannabinoid'
[patent_app_type] => utility
[patent_app_number] => 14/851378
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6128
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851378
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/851378 | Use for cannabinoid | Sep 10, 2015 | Issued |
Array
(
[id] => 10774839
[patent_doc_number] => 20160120995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/848396
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21996
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14848396
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/848396 | CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF | Sep 8, 2015 | Abandoned |
Array
(
[id] => 10774720
[patent_doc_number] => 20160120876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER USING PHENOTHIAZINE'
[patent_app_type] => utility
[patent_app_number] => 14/841727
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15091
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14841727
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/841727 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER USING PHENOTHIAZINE | Aug 31, 2015 | Abandoned |
Array
(
[id] => 10669564
[patent_doc_number] => 20160015710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'Methods of Treating Multiple Myeloma and Resistant Cancers'
[patent_app_type] => utility
[patent_app_number] => 14/831798
[patent_app_country] => US
[patent_app_date] => 2015-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14378
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831798
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/831798 | Methods of Treating Multiple Myeloma and Resistant Cancers | Aug 19, 2015 | Abandoned |
Array
(
[id] => 11850167
[patent_doc_number] => 20170224659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'A COMPOSITION HAVING A MUSCLE-RELAXANT AND ANTI-INFLAMMATORY ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/503082
[patent_app_country] => US
[patent_app_date] => 2015-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4249
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503082
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503082 | Composition having a muscle-relaxant and anti-inflammatory activity | Aug 17, 2015 | Issued |
Array
(
[id] => 10474872
[patent_doc_number] => 20150359889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'Cardiac arrest muscle relaxant'
[patent_app_type] => utility
[patent_app_number] => 14/756204
[patent_app_country] => US
[patent_app_date] => 2015-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 123
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14756204
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/756204 | Cardiac arrest muscle relaxant | Aug 16, 2015 | Abandoned |
Array
(
[id] => 10459489
[patent_doc_number] => 20150344503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'INHIBITORS OF FATTY ACID AMIDE HYDROLASE, METHODS OF TREATMENT AND METHODS OF PREPARING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/828318
[patent_app_country] => US
[patent_app_date] => 2015-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36846
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14828318
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/828318 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE, METHODS OF TREATMENT AND METHODS OF PREPARING SAME | Aug 16, 2015 | Abandoned |
Array
(
[id] => 13151677
[patent_doc_number] => 10092541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast
[patent_app_type] => utility
[patent_app_number] => 14/826027
[patent_app_country] => US
[patent_app_date] => 2015-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14287
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14826027
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/826027 | Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast | Aug 12, 2015 | Issued |
Array
(
[id] => 10821935
[patent_doc_number] => 20160168099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/825477
[patent_app_country] => US
[patent_app_date] => 2015-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 15148
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14825477
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/825477 | NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE | Aug 12, 2015 | Abandoned |
Array
(
[id] => 10737205
[patent_doc_number] => 20160083355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'COMPOUNDS WHICH HAVE A PROTECTIVE ACTIVITY WITH RESPECT TO THE ACTION OF TOXINS AND OF VIRUSES WITH AN INTRACELLULAR MODE OF ACTION'
[patent_app_type] => utility
[patent_app_number] => 14/810342
[patent_app_country] => US
[patent_app_date] => 2015-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28137
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14810342
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/810342 | COMPOUNDS WHICH HAVE A PROTECTIVE ACTIVITY WITH RESPECT TO THE ACTION OF TOXINS AND OF VIRUSES WITH AN INTRACELLULAR MODE OF ACTION | Jul 26, 2015 | Abandoned |
Array
(
[id] => 11820439
[patent_doc_number] => 20170209377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'POLYVINYL ALCOHOL PARTICLES, PHARMACEUTICAL BINDER USING SAME, PHARMACEUTICAL TABLET, SUSTAINED-RELEASE PHARMACEUTICAL TABLET, AND METHOD FOR PRODUCING POLYVINYL ALCOHOL PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/328580
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8286
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328580 | Polyvinyl alcohol particles, pharmaceutical binder using same, pharmaceutical tablet, sustained-release pharmaceutical tablet, and method for producing polyvinyl alcohol particles | Jul 23, 2015 | Issued |
Array
(
[id] => 16025703
[patent_doc_number] => 10675251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Particles containing branched polymers
[patent_app_type] => utility
[patent_app_number] => 15/326775
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 14618
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326775 | Particles containing branched polymers | Jul 16, 2015 | Issued |
Array
(
[id] => 10481944
[patent_doc_number] => 20150366962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'SYNTHETIC TLR4 AND TLR7 LIGANDS AS VACCINE ADJUVANTS'
[patent_app_type] => utility
[patent_app_number] => 14/745394
[patent_app_country] => US
[patent_app_date] => 2015-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 29781
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745394
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745394 | SYNTHETIC TLR4 AND TLR7 LIGANDS AS VACCINE ADJUVANTS | Jun 19, 2015 | Abandoned |
Array
(
[id] => 13410015
[patent_doc_number] => 20180256550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => TARGET FOR TREATING HEPATITIS B VIRUS
[patent_app_type] => utility
[patent_app_number] => 15/571154
[patent_app_country] => US
[patent_app_date] => 2015-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/571154 | Target for treating hepatitis B virus | Jun 14, 2015 | Issued |